• Profile
Close

Biomarker enhanced risk prediction for development of AKI after cardiac surgery

BMC Nephrology May 09, 2018

Merchant ML, et al. - Experts intended to identify preoperative candidate urine biomarkers in patients undergoing cardiac surgery. The researchers concluded that pre-operative urine measurement of complement factor B (CFB) or histidine rich glycoprotein (HRG) significantly enhanced the current post-surgery acute kidney injury (AKI) risk stratification for a more restrictive definition of AKI. Findings revealed that HRG, but not CFB or clinical risk stratification, predicted AKI defined by Kidney Disease Improving Global Outcomes (KDIGO), however, the ability of these biomarkers to predict risk for dialysis-requiring AKI or death could not be reliably evaluated due to a small number of patients with either outcome.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay